概述

  • 产品名称
    Anti-Bcr-abl抗体[7C6]
    参阅全部 Bcr-abl 一抗
  • 描述
    小鼠单克隆抗体[7C6] to Bcr-abl
  • 宿主
    Mouse
  • 特异性
    ab187831 recognizes an epitope within the amino acid sequence SSINEEITPRRQS of Bcr/Abl.
  • 经测试应用
    适用于: IHC-P, ICC/IF, IP, WBmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    Synthetic peptide within Human Bcr-abl. The exact sequence is proprietary. (Bcr686 thyroglobulin conjugate)
    Sequence:

    SSINEEITPRRQS


    Database link: A9UFO7

  • 表位
    Cells from immunized Balb/c mice were fused with the P3X63Ag8 myeloma cell line.
  • 阳性对照
    • WB: K562 cell lysates. ICC/IF: K562 cells. IHC-P: Human hepatocarcinoma, human breast carcinoma and mouse liver tissue. IP: K562 whole cell lysate.

性能

应用

Our Abpromise guarantee covers the use of ab187831 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IHC-P 1/200.
ICC/IF 1/50 - 1/100.
IP Use at an assay dependent concentration.
WB 1/500 - 1/1000. Predicted molecular weight: 197 kDa.

靶标

  • 相关性
    The BCR gene is involved in the 9:22 translocation that generates the Philadelphia chromosome both in chronic myeloid leukemia (CML) and in a proportion of cases of acute lymphocytic leukemia (ALL). A 5' bcr sequence becomes fused to an abl sequence (including tyrosine kinase domain sequences) from chromosome 9 and results in the production of a chimaeric BCR-ABL protein with enhanced kinase activity. These antibodies may be useful for studies of the oncogene and have potential diagnostic and prognostic applications.
  • 数据库链接
  • 别名
    • ALL antibody
    • BCR ABL fusion antibody
    • BCR ABL fusion protein antibody
    • BCR antibody
    • BCR/ABL fusion antibody
    • BCR/ABL fusion protein antibody
    • Bcr/c abl oncogene protein antibody
    • BCRe18/ABL1e3 fusion protein antibody
    • Breakpoint cluster region antibody
    • CML antibody
    see all

图片

  •  
  •  
  • Immunocytochemistry/Immunofluorescence analysis of K562 cells labelling Bcr-able (green) with ab187831. Cells were fixed with formalin and permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature. Cells were blocked with 1% blocker BSA for 15 minutes at room temperature. Cells were incubated with the primary antibody at a dilution of 1/50 for 1 hour at room temperature, washed with PBS, and incubated with a DyLight 488-conjugated goat anti-mouse IgG secondary antibody. Nuclei (blue) were stained with Hoechst 33342 dye. Images were taken at 20X magnification.

  • Immunoprecipitation of BCR-ABL and BCR was performed using K562 whole cell lysate. Antigen-antibody complexes were formed by incubating 800 µg of lysate with 5 µg of ab187831 overnight on a rocking platform at 4°C. The immune complexes were captured on 50 µl Protein A/G Agarose, washed extensively, and eluted. The sample was resolved on a 4-20% Tris-HCl polyacrylamide gel, transferred to a PVDF membrane, and blocked with 5% BSA/TBS-0.1% Tween for 1 hour. The membrane was probed with a phosphotyrosine monoclonal antibody (detecting p-Tyr-BCR-ABL/p-Tyr-BCR) at a dilution of 1/1000 overnight rotating at 4°C, washed in TBST, and probed with a goat anti-mouse IgG-HRP secondary antibody at a dilution of 1/20,000 for 1 hour. Chemiluminescent detection was performed.

  •  
  •  

文献

This product has been referenced in:
  • Zhang C  et al. Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cells. Oncol Lett 13:2059-2070 (2017). WB . Read more (PubMed: 28454362) »

See 1 Publication for this product

客户评价及客户问答

There are currently no Customer reviews or Questions for ab187831.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册